|
1
|
Smith-Morris C, Bresnick GH, Cuadros J,
Bouskill KE and Pedersen ER: Diabetic retinopathy and the cascade
into vision loss. Med Anthropol. 17:1–14. 2018. View Article : Google Scholar
|
|
2
|
Gella L, Raman R, Pal SS, Ganesan S and
Sharma T: Incidence, progression, and associated risk factors of
posterior vitreous detachment in type 2 diabetes mellitus: Sankara
nethralaya diabetic retinopathy epidemiology and molecular genetic
study (SN-DREAMS II, Report No. 7). Semin Ophthalmol. 32:191–197.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Raman R, Ganesan S, Pal SS, Gella L,
Kulothungan V and Sharma T: Incidence and progression of diabetic
retinopathy in urban India: Sankara nethralaya-diabetic retinopathy
epidemiology and molecular genetics study (SN-DREAMS II), Report 1.
Ophthalmic Epidemiol. 24:294–302. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Capitão M and Soares R: Angiogenesis and
inflammation crosstalk in diabetic retinopathy. J Cell Biochem.
117:2443–2453. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou L, Zhang T, Lu B, Yu Z, Mei X,
Abulizi P and Ji L: Lonicerae Japonicae Flos attenuates diabetic
retinopathy by inhibiting retinal angiogenesis. J Ethnopharmacol.
189:117–125. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tanaka M, Takagi T, Naito Y, Uchiyama K,
Hotta Y, Toyokawa Y, Ushiroda C, Hirai Y, Aoi W, Higashimura Y, et
al: Secreted protein acidic and rich in cysteine functions in
colitis via IL17A regulation in mucosal CD4+ T cells. J
Gastroenterol Hepatol. 33:671–680. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Toyota K, Murakami Y, Kondo N, Uemura K,
Nakagawa N, Takahashi S and Sueda T: Impact of secreted protein
acidic and rich in cysteine (SPARC) expression on prognosis after
surgical resection for biliary carcinoma. J Gastrointest Surg.
21:990–999. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kos K and Wilding JP: SPARC: A key player
in the pathologies associated with obesity and diabetes. Nat Rev
Endocrinol. 6:225–235. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu L, Ping F, Yin J, Xiao X, Xiang H,
Ballantyne CM, Wu H and Li M: Elevated plasma SPARC levels are
associated with insulin resistance, dyslipidemia, and inflammation
in gestational diabetes mellitus. PLoS One. 8:e816152013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu D, Li L, Yang M, Liu H and Yang G:
Elevated plasma levels of SPARC in patients with newly diagnosed
type 2 diabetes mellitus. Eur J Endocrinol. 165:597–601. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jandeleit-Dahm K, Rumble J, Cox AJ, Kelly
DJ, Dziadek M, Cooper ME and Gilbert RE: SPARC gene expression is
increased in diabetes-related mesenteric vascular hypertrophy.
Microvasc Res. 59:61–71. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zufferey R, Nagy D, Mandel RJ, Naldini L
and Trono D: Multiply attenuated lentiviral vector achieves
efficient gene delivery in vivo. Nat Biotechnol. 15:871–875. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang W, Yan Z, Li D, Ma Y, Zhou J and Sui
Z: Antioxidant and anti-inflammatory effects of blueberry
anthocyanins on high glucose-induced human retinal capillary
endothelial cells. Oxid Med Cell Longev. 2018:18624622018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Farjo KM, Farjo RA, Halsey S, Moiseyev G
and Ma JX: Retinol-binding protein 4 induces inflammation in human
endothelial cells by an NADPH oxidase- and nuclear factor kappa
B-dependent and retinol-independent mechanism. Mol Cell Biol.
32:5103–5115. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Francescone RA III, Faibish M and Shao R:
A Matrigel-based tube formation assay to assess the vasculogenic
activity of tumor cells. J Vis Exp. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Landt S, Heidecke H, Korlach S, Reuter C,
Schwidde I, Barinoff J, Thill M, Sehouli J and Kümmel S: In vitro
vascular tube formation testing as a tool for treatment
individualisation in patients with cervical cancer. Anticancer Res.
31:2609–2615. 2011.PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chlenski A, Dobratic M, Salwen HR,
Applebaum M, Guerrero LJ, Miller R, DeWane G, Solomaha E, Marks JD
and Cohn SL: Secreted protein acidic and rich in cysteine (SPARC)
induces lipotoxicity in neuroblastoma by regulating transport of
albumin complexed with fatty acids. Oncotarget. 7:77696–77706.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kao SC, Kirschner MB, Cooper WA, Tran T,
Burgers S, Wright C, Korse T, van den Broek D, Edelman J, Vallely
M, et al: A proteomics-based approach identifies secreted protein
acidic and rich in cysteine as a prognostic biomarker in malignant
pleural mesothelioma. Br J Cancer. 114:524–531. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Abe T, Takahashi S and Suzuki N: Oxidative
metabolism in cultured rat astroglia: Effects of reducing the
glucose concentration in the culture medium and of D-aspartate or
potassium stimulation. J Cereb Blood Flow Metab. 26:153–160. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Norose K, Lo WK, Clark JI, Sage EH and
Howe CC: Lenses of SPARC-null mice exhibit an abnormal cell
surface-basement membrane interface. Exp Eye Res. 71:295–307. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bornstein P: Diversity of function is
inherent in matricellular proteins: An appraisal of thrombospondin
1. J Cell Biol. 130:503–506. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bailey-Serres J, Sorenson R and Juntawong
P: Getting the message across: Cytoplasmic ribonucleoprotein
complexes. Trends Plant Sci. 14:443–453. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Watanabe K, Okamoto F, Yokoo T, Iida KT,
Suzuki H, Shimano H, Oshika T, Yamada N and Toyoshima H: SPARC is a
major secretory gene expressed and involved in the development of
proliferative diabetic retinopathy. J Atheroscler Thromb. 16:69–76.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Song SJ, Han K, Choi KS, Ko SH, Rhee EJ,
Park CY, Park JY, Lee KU and Ko KS: Task Force Team for Diabetes
Fact Sheet of the Korean Diabetes Association: Trends in diabetic
retinopathy and related medical practices among type 2 diabetes
patients: Results from the National Insurance Service Survey
2006–2013. J Diabetes Investig. 9:173–178. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang FH, Sun XD, Zhang X, Xu X, Zhu Q,
Huang JN, Fan Y, Gu Q and Liu HY: Role of pigment
epithelium-derived factor on proliferation and migration of
choroidal capillary endothelium induced by vascular endothelial
growth factor in vitro. Chin Med J (Engl). 120:1534–1538.
2007.PubMed/NCBI
|
|
27
|
Wang X, Wang G and Wang Y: Intravitreous
vascular endothelial growth factor and hypoxia-inducible factor 1a
in patients with proliferative diabetic retinopathy. Am J
Ophthalmol. 148:883–889. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rubsam A, Parikh S and Fort PE: Role of
inflammation in diabetic retinopathy. Int J Mol Sci. 19:pii: E942.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rivera LB, Bradshaw AD and Brekken RA: The
regulatory function of SPARC in vascular biology. Cell Mol Life
Sci. 68:3165–3173. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang JL, Chen GW, Liu YC, Wang PY, Wang
X, Wan YL, Zhu J, Gao HQ, Yin J, Wang W and Tian ML: Secreted
protein acidic and rich in cysteine (SPARC) suppresses angiogenesis
by down-regulating the expression of VEGF and MMP-7 in gastric
cancer. PLoS One. 7:e446182012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Boyineni J, Tanpure S, Gnanamony M, Antony
R, Fernández KS, Lin J, Pinson D and Gondi CS: SPARC overexpression
combined with radiation retards angiogenesis by suppressing VEGF-A
via miR410 in human neuroblastoma cells. Int J Oncol. 49:1394–1406.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rahimi N: Defenders and challengers of
endothelial barrier function. Front Immunol. 8:18472018. View Article : Google Scholar
|
|
33
|
Klaassen I, Van Noorden CJ and
Schlingemann RO: Molecular basis of the inner blood-retinal barrier
and its breakdown in diabetic macular edema and other pathological
conditions. Prog Retin Eye Res. 34:19–48. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tan GS, Cheung N, Simo R, Cheung GC and
Wong TY: Diabetic macular oedema. Lancet Diabetes Endocrinol.
5:143–155. 2017. View Article : Google Scholar : PubMed/NCBI
|
